Recombinant polypeptides derived from the fibrin binding domain of fibronectin are potential agents for the imaging of blood clots

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 796-803

  Ezov, N ^a   Nimrod, A ^a   Parizada, B ^a   Werber, M M ^a   Goldlust, A ^a   Greenstein, L A ^a   Vogel, T ^a   Drizlich, N ^a   Levanon, A ^a   Reich, S ^a   Gorecki, M ^a   Panet, A ^a  

^a Bio Technology General Inc   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRONECTIN; GLUTAMINE; HEPARIN; POLYPEPTIDE; PUTRESCINE; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD CLOT; CONTROLLED STUDY; COVALENT BOND; DIAGNOSTIC IMAGING; FIBRIN CLOT; HUMAN; HUMAN CELL; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RABBIT; RAT; THROMBOGENESIS; THROMBUS; VEIN THROMBOSIS;

EID: 0030891626     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656052     Document Type: Article

References (31)

1. Gracia-Pardo A, Pearlstein E, Frangione B. Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain. J Biol Chem 1983; 258: 12670-4.
2. Akiyama SK, Yamada KM. Fibronectin. Adv Enzymol Relat Areas Mol Biol 1987; 59: 1-57.
3. Proctor RA, Mosher DF, Olbrantz PG. Fibronectin binding to Staphylococcus aureus. J Biol Chem 1982; 257: 14788-94.
4. Ruoslathi E. Fibronectin and its receptors. Annual Rev Biochem 1988; 57: 375-413. ed. Richardson CC.
5. Knight LC. Scintigraphic Methods of Detecting Vascular Thrombus. J Nucl Med 1993; 34: 554-61.
6. Uehara A, Isaka Y, Hashikawa K, Kimura K, Kozuka T, Kamada T, Etahi H, Yoneda S, Imaizumi M. Iodine-131 labeled fibronectin: potential agent for imaging atheroslerotic lesion and thrombus. J Nucl Med 1988; 29: 1264-7.
7. Büller HR, Lensing AWA, Hirsh J, ten Cate JW. Deep vein thrombosis: New non-invasive diagnostic tests. Thromb Haemost 1991; 66: 133-7.
8. Kornblihtt AR, Umezawa K, Vibe-Pederson K, Baralle FE. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 1985; 4: 1755-9.
9. Hartman JR, Geller T, Yavin Z, Bartfeld D, Kanner D, Aviv H, Gorecki M. High-level expression of enzymatically active human Cu/Zn superoxide dismutase in Escherichia coli. Proc Natl Acad Sci USA 1986; 83: 7142-6.
10. Werber MM, Vogel T, Greenstein LA, Levanon A, Zelig Y, Havron A, Gorecki M, Panel A. Large-scale purification and refolding of recombinant proteins derived from fibronectin domains. In: Biologicals from Recombinant Microorganisims and Animal Cells. White MD, ed. Production and Recovery 1991; pp 369-82.
11. Hayashi M, Yamada KM. Domain structure of the carboxyl-terminal half of human plasma fibronectin. J Biol Chem 1983; 258: 3332-40.
12. Vogel Z, Sytkowski AJ, Nirenberg MW. Acetylcholine receptors of muscle grown in vitro. Proc Natl Acad Sci USA 1972; 69: 3180-4.
13. 125I-containing acylating agent. Biochem J 1973; 133: 529-39.
14. Hnatowich DJ, Layne WW, Childs RL. The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isolt 1982; 35: 327-32.
15. Knight LC, Maurer AH, Ammar IA, Epps LA, Dean RT, Pak KY, Berger HJ. Tc-99m antifibrin Fab' fragments for imaging venous thrombi: evaluation in a canine model. Radiology 1989; 173: 163-9.
16. 2-terminal fibrin-binding site on fibronectin. J Biol Chem 1994; 269: 31938-45.
17. Maffrand JP, Bernat A, Delebassee D, Defreyn G, Cazenave JP, Gordon JL. ADP plays a key role in thrombogenesis in rats. Thromb Haemost 1988; 59: 225-30.
18. Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest 1983; 71: 368-76.
19. Brumfeld V, Werber MM. Studies on Fibronectin and its Domains. II. Secondary structure and spatial configuration of fibronectin and of its domains. Arch Biochem Biophys 1993; 302: 134-43.
20. Ichihara-Tanaka K, Titani K, Sekiguchi K. Recombinant carboxy-terminal fibrin-binding of human fibronectin expressed in mouse L cells. J Biol Chem 1990; 265: 401-7.
21. Vogel T, Werber MM, Guy R, Levanon A, Nimrod A, Legrand C, Gorecki M, Eldor A, Panet A. Studies on fibronectin and its domains I. Novel recombinant cell binding domain of fibronectin - a modulator of human platelet functions. Arch Biochem Biophys 1993; 300: 501-9.
22. Mosher DF, Johnson RB. In vitro formation of disulfide-bonded fibronectin multimers. J Biol Chem 1983; 258: 6595-601.
23. Sottile J, Schwarzbauer J, Selegue J, Mosher DF. Five type I modules of fibronectin form a functional unit that binds to fibroblasts and Staphylococcus aureus. J Biol Chem 1991; 266: 12840-3.
24. Yamamoto K, Senda M, Fujita T, Kumada K, Fukui K, Yonekura Y, Yokoyama A, Torizuka K. Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen. Eur J Nucl Med 1988; 14: 60-4.
25. Knight LC. Imaging with radiolabelled anti-fibrin monoclonal antibodies. Nucl Med Commun 1988; 9: 823-9.
26. Knight LC, Abrams MJ, Schwartz DA, Hauser MM, Kollman M, Gaul FE, Rauh DA, Maurer AH. Preparation and preliminary evaluation of technetium-99m-labeled fragment E1 for thrombus imaging. J Nuclear Med 1992; 33: 710-5.
27. Wasser MN, Koppert PW, Arndt JW, Emeis JJ, Feitsma RI, Pauwels EK, Nieuwenhuizen W. An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi. Blood 1989; 74: 708-14.
28. Som P, Oster ZH, Zamora P, Yamamoto K, Sacker DF, Brill AB, Newell KD, Rhodes BA. Radioimmuno imaging of experimental thrombi in dogs using technetium-99m-labeled monoclonal antibody fragments reactive with human platelets. J Nuclear Med 1986; 27: 1315-20.
29. Palabrica TM, Furie BC, Konstam MA, Aronovitz MJ, Connolly R, Brockway BA, Ramberg KL, Furie B. Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets. Proc Natl Acad Sci USA 1989; 86: 1036-40.
30. 111In labeled fibrin binding domain (FBD). Abs. 475, Proceedings of the Society of Nuclear Medicine Meeting, Toronto 1993.
31. Werber MM, Kook M, Greenstein LA, Goldlust A, Levanon A, Gorecki M, Panel A, Vogel T. Refolding and purification of recombinant proteins derived from fibronectin's fibrin binding domain. Proceedings of the 6th Symposium of the Protein Society, San Diego, CA, July 1992. Abstract No. T25.